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thologist remained nearly constant in both rounds of exam-
ination (differences  ^  0.05 grade points) but differed be-
tween the two pathologists (up to 0.4 grade points). In mul-
tivariable analyses, the prognostic impact of the BGS in 
terms of CSS was strongly pathologist-dependent.  Conclu-
sions: Clinically and prognostically relevant interobserver 
discordance concerning the BGS seems, at least in part, to be 
attributable to inherent ‘aggressive’ versus ‘reserved’ grad-
ing characteristics of individual pathologists. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 In surgical pathology practice, reproducibility of the 
histologic grading of penile squamous cell carcinomas 
(PSCCs) might be substantially confounded by the well-
known problem of interobserver variation  [1] .
 However, the clinical importance conveyed by the his-
tologic grading of squamous cell carcinomas rendered by 
the pathologist cannot be overstressed as it not only rep-
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 Abstract 
 Introduction: We assessed the reproducibility and prognos-
tic impact of the Broders’ grading system (BGS) in a cohort 
of 147 patients with surgically treated penile squamous cell 
carcinomas.  Materials and Methods: Conventionally stained 
histology slides were graded according to the BGS in two 
rounds by two study pathologists. Reproducibility was as-
sessed using   statistics. Multivariable analyses were calcu-
lated to predict cancer-specific survival (CSS). The ‘mean 
grade’ per pathologist per round was calculated by allocat-
ing grade points to each study case (G1–G4: 1–4 points) and 
dividing the sum of all grade points by the number of cases 
examined.  Results: The BGS showed substantial interob-
server variation (59–87% with   = 0.38–0.69) but almost per-
fect intraobserver reproducibility (91% with   = 0.86 and 
96% with   = 0.94, respectively). The ‘mean grade’ per pa-
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resents an independent prognostic parameter by itself, 
but also might strongly influence clinical management. 
For example, a patient with pT1aG2 PSCC will usually be 
spared inguinal lymph node dissection (ILND) unless 
the inguinal nodes appear to be involved clinically, 
whereas assigning the G3 category to that case would lead 
to upstaging to pT1b disease, which necessitates ILND, a 
procedure not to be underestimated in terms of possible 
comorbidity  [2–9] .
 To date, only one study has assessed the reproducibil-
ity of histologic grading in 75 patients with surgically 
treated PSCCs, but unfortunately, it used different grad-
ing schemes which are not directly comparable  [1] .
 We present the first comprehensive multicenter study 
looking at the interobserver reproducibility of the Bro-
ders’ grading system (BGS) in a study cohort enrolling 
147 patients with surgically treated PSCC. Moreover, by 
calculating the ‘mean grade’ per pathologist and using 
multivariable Cox models for predicting cancer-specific 
survival (CSS), we sought to determine the magnitude of 
the prognostic impact conveyed by the interobserver dis-
cordance with respect to the BGS.
 Methods 
 Study Patients 
 Our previously evaluated study cohort was expanded by an-
other 55 study cases retrieved from the files of the Department of 
Pathology, University Hospital Regensburg, Germany  [10] . Hence, 
a total of 147 consecutive patients surgically treated for PSCC be-
tween 1993 and 2010 in 7 different German hospitals (35 total and 
112 partial penectomies) were evaluated in the present study. At 
surgery, all patients were free of distant metastasis (cM0) and had 
histologically uninvolved surgical margins. Of the 147 patients, 
48 (33%) underwent ILND on the basis of clinically enlarged in-
guinal nodes and/or tumor stage and grade. By these indications 
standardized across the hospitals involved, 99 patients (67%) were 
spared ILND. Mean patient age at surgery was 66.5 years (range 
29–92, SD 11.8) ( table 1 ).
 Pathological processing of penectomies followed similar ana-
tomical landmarks  [11] . Tumor thickness (vertical depth of infil-
tration from the granular cell layer of the adjacent epithelium or 
from the base of the ulcer to the deepest point of invasion) and 
lymphovascular invasion (LVI), defined as the unequivocal con-
ventional histologic presence of tumor emboli within endotheli-
um-lined spaces, were recorded. Patients were dichotomized 
based on tumor thickness (cutoff 5 mm), as previously reported 
elsewhere  [12] . Grading was performed according to the BGS 
since the latter was consistently employed by the 7 pathology de-
partments involved in this study  [13] . Staging and follow-up were 
performed according to the guidelines of the European Associa-
tion of Urology  [8] . After institutional review board approval was 
obtained from the Medical Ethics Committee of the federal state 
of Brandenburg, Germany (Landesärztekammer Brandenburg; 
MEC No. 37588/11), CSS was obtained for all study patients.
 Central Histopathologic Review and Reexamination of the 
Study Cases 
 All retrieved slides obtained from 147 study specimens (all his-
tologically confirmed primary PSCCs) were reexamined by one 
study pathologist (S.G.), who selected representative study slides 
(median 3, range 1–6 slides) from each study case to be forwarded 
to a second independent study pathologist (D.M.) and reevaluated 
stage, LVI and tumor thickness while blinded to the retrieved 
original pathology reports. The second study pathologist re-
viewed the selected study slides for stage, LVI and tumor thick-
ness. The two study pathologists underwent their training in dif-
ferent institutions and never practiced together. No subdivision 
of pT1 stage was performed to avoid potential confounding bias. 
Four study cases were assigned discrepant stages by the study pa-
thologists. These cases were examined by a third clinical patholo-
gist (S.K.), and the consensus pT stage assigned by the majority of 
raters was recorded. Moreover, based on a consensus decision, one 
additional patient had LVI. Regarding histologic evaluation of all 
other parameters, there was complete concordance amongst both 
study pathologists.
Table 1. P ertinent clinical and pathological characteristics of the 
study cohort (n = 147)
Characteristic
Age at surgery1, years 66.5811.8
Treatment of primary tumor
Total penectomy 35 (23.8)
Partial penectomy 112 (76.2)
Tumor size2, cm 1.9 (1.2–2.6)
Tumor thickness
≤5 mm 48 (32.7)
>5 mm 99 (67.3)
LVI present (L1 and/or V1) 54 (36.7)
2010 pathological primary tumor classification3
pTa/pTis 5 (3.4)
pT1 74 (50.3)
pT2 38 (25.9)
PT3 30 (20.4)
pT4 0
2010 pathological regional lymph node involvement
pN0/pNx 119 (80.9)
pN1 13 (8.9)
pN2 15 (10.2)
Tumor grade (local pathology) 
TG1 44 (29.9)
TG2 89 (60.5)
TG3 14 (9.5)
TG4 0
Values represent numbers of patients and percentages in pa-
rentheses, except where indicated otherwise.
1 Mean 8 SD. 2 Median and interquartile range. 3 Consensus 
decision.
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 Then, both study pathologists held a joint meeting in which 
they examined 18 randomly selected PSCC specimens using a 
multihead microscope and discussed the Broders’ criteria to be 
employed. A few weeks later, all study slides were circulated in two 
rounds to both study pathologists for histologic grading based 
upon the BGS. Both raters were blinded to patient ID, clinical 
data, stage and grade rendered in the original pathology reports, 
as well as the diagnostic categories previously allocated by them-
selves and by the other study pathologist.
 Statistical Analysis 
 The Shapiro-Wilk normality test was used to investigate nor-
mal distribution of continuous variables. Continuous, evenly dis-
tributed variables are reported as means  8 SD. Continuous non-
normally distributed variables are presented as medians with in-
terquartile ranges. For normally distributed variables, Student’s t 
test was applied. The Mann-Whitney test was used for nonnor-
mally distributed variables. The individual ‘mean grade’ of both 
study pathologists was calculated separately for their first and sec-
ond round of histologic examination by allocating points to the 
different grading categories (G1–G4: 1–4 points) and by dividing 
the sum of all grade points by 147 as previously reported elsewhere 
 [14] . In contrast, concerning the 7 independent local pathologists, 
their individual ‘mean grade’ was calculated based upon the sum 
of the grading categories rendered in their original pathology re-
ports divided by the number of study cases retrieved from their 
corresponding files  [14] .
 Cohen’s weighted   statistics were employed to assess repro-
ducibility. CSS obtained from death certificates was defined as 
the end point to be incorporated in uni- and multivariable anal-
yses and was calculated by the Kaplan-Meier method as the pe-
riod of time between primary surgery and cancer-related death. 
The log-rank test was used to compare the survival curves. Uni-
variable analyses were performed in order to assess the prognos-
tic impact of every recorded parameter with respect to CSS. 
Moreover, five different multivariable Cox proportional hazards 
regression models were created in order to statistically evaluate 
the prognostic impact conveyed by the histologic grades ren-
dered by the local pathologists as well as by the raters A and B 
during their first and second round of histologic examination 
with respect to CSS.
 The build-up quality of the different multivariable Cox models 
was assessed by using the omnibus test in order to compare the 
model coefficients. Briefly, compared with a basic model (Cox 
model with exclusion of histologic grade), the changing deviance 
(–2 multiplied log-likelihood) was analyzed by means of the de-
velopment of   2 (percentage change of model quality including 
the affiliated p values compared with the multivariable Cox mod-
el with incorporation of histologic grade). The contribution of the 
models’ quality accuracy conveyed by those variables retained in 
the different models was analyzed by means of the ‘area under 
curve’ (AUC), substituted by Harrell’s concordance index. The 
significance of the differences in accuracy estimates was tested 
using the Mantel-Haenszel test, which compared related AUCs 
 [15, 16] .
 Statistical analyses were performed using SPSS  17.0 (SPSS 
Inc., Chicago, Ill., USA) and StatView  , version 5.0 (SAS Institute 
Inc., Cary, N.C., USA). p values are two-sided, with the statistical 
significance level set at p  ! 0.05.
 Results 
 Interobserver Reproducibility of Histopathologic 
Parameters 
 Comparison of the grading categories assigned by the 
7 local pathologists and by both study pathologists 
showed discrepancies between G1/2 and G2/3 only ( ta-
ble 2 ). Conformity varied between 59.2 and 87.7%.   val-
ues ranged between 0.378 and 0.692 ( table 3 ). Regarding 
classification of tumor stage, LVI and dichotomized tu-
mor thickness, both study pathologists showed complete 
concordance.
 Intraobserver Reproducibility and ‘Mean Grade’ per 
Pathologist 
 Both study pathologists had almost perfect intraob-
server agreement between their first and second round 
(91.1% and   = 0.862 vs. 96.5% and   = 0.942;  table 3 ), 
which resulted in a nearly constant individual ‘mean 
grade’ in both rounds (rater A: 1.96 vs. 2.01, p = 0.575; 
rater B: 1.60 vs. 1.61, p = 0.932;  table  4 ). However, the 
‘mean grades’ assigned by the 7 independent local pathol-
ogists and by both study pathologists differed signifi-
cantly, as did the ‘mean grades’ assigned by both study 
pathologists (p values  ! 0.001;  table 4 ;  fig. 1 ,  2 ). Whereas 
study pathologist A (highest ‘mean grade’) and B (lowest 
‘mean grade’) showed the poorest interobserver agree-
ment, the highest interobserver concordance was found 
when the study pathologists A and B were compared with 
the 7 local pathologists. These data indicate that the mag-
Table 2. C omparison of the Broders’ grading categories allocated 
to the study cases (n = 147) by both study pathologists (raters A 
and B) in both rounds of examination
TG1
(rater B)
TG2
(rater B)
TG3
(rater B)
Total
First round
TG1 (rater A) 44 0 0 44
TG2 (rater A) 31 34 0 65
TG3 (rater A) 0 22 16 38
Total 75 56 16 147
Second round
TG1 (rater A) 36 0 0 36
TG2 (rater A) 38 36 0 74
TG3 (rater A) 0 21 16 37
Total 74 57 16 147
T G1–3 = Tumor grades G1–G3 (Broders’ grade G4 did not oc-
cur in the present series).
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nitude of interobserver discordance seems to be closely 
related to the magnitude of the difference in their ‘mean 
grade’, which obviously reflects inherent ‘aggressive’ ver-
sus ‘reserved’ grading characteristics.
 Prognostic Impact of the ‘Mean Grade’ per Pathologist 
on CSS in Uni- and Multivariable Analysis 
 Median follow-up of the patients alive was 39 months 
(interquartile range 20–72). CSS rates for the entire study 
cohort after 1, 3 and 7 years were 91, 70 and 61%. In the 
univariable analysis, grades assigned by the 7 local pa-
thologists and by the study pathologists A and B signifi-
cantly predicted CSS (p values  ! 0.001;  table 4 ). Moreover, 
univariable analyses showed the following parameters to 
significantly predict CSS: type of surgery, tumor size, tu-
mor thickness (cutoff 5 mm), LVI, tumor stage, pN stage 
and histologic grade ( table 5 ). The multivariable analyses 
confirmed an independent prognostic contribution of 
histopathologic stage and nodal status. Moreover, 3 out 
of the 5 different multivariable Cox models created dis-
closed histologic grade, LVI and patient age at surgery to 
be significantly associated with CSS ( table 6 ). However, 
the prognostic impact conveyed by the histologic grade 
was found to be strongly pathologist-dependent ( table 6 ). 
In particular, the grading rendered by rater B in both 
rounds conveyed a significant independent prognostic 
impact on CSS, whereas the grading rendered by rater A 
only represented an independent prognostic parameter 
in the second round of examination, while failing to 
reach statistical significance in the first round. Converse-
ly, the grading rendered by the local pathologists failed to 
convey any independent prognostic impact in terms of 
CSS in our multivariable analysis.
 Depending upon the incorporation of histologic tu-
mor grade, the different multivariable models showed 
concordance indices between 0.78 and 0.81 (all p values 
comparing AUCs were  1 0.1). The improvement of the 
model quality achieved by incorporation of histologic tu-
mor grade ranged between 0.01 and 6.6% ( table 6 ).
 Discussion 
 The histologic grading of surgically treated PSCC 
might strongly guide clinical management at present. For 
example, a patient with pT1aG2 PSCC with clinically un-
remarkable regional nodes will usually be spared ILND, 
whereas assigning the G3 category to that case would lead 
to upstaging of the disease (pT1b stage), necessitating 
Table 3. A greement between both study pathologists (raters A and B) and 7 independent local pathologists with respect to histologic 
grading
Local pathologists Rater A R ater B
1st round 2nd round 1st round 2nd round
Local pathologists – 87.7%,  = 0.692 73.4%,  = 0.556 69.4%,  = 0.495 68.7%,  = 0.482
Rater A (1st round) 87.7%,  = 0.692 – 91.1%,  = 0.862 63.9%,  = 0.446 63.2%,  = 0.435
Rater A (2nd round) 73.4%,  = 0.556 91.1%,  = 0.862 – 59.2%,  = 0.378 59.9%,  = 0.386
Rater B (1st round) 69.4%,  = 0.495 63.9%,  = 0.446 59.2%,  = 0.378 – 96.5%,  = 0.942
Rater B (2nd round) 68.7%,  = 0.482 63.2%,  = 0.435 59.9%,  = 0.386 96.5%,  = 0.942 –
Results are presented separately for the first and second grading round performed by both study pathologists as conformity (per-
centage) and  value.
Table 4. P rognostic implications conveyed by the ‘mean grade’
in terms of CSS after 3 years 
Mean grade 
8 SE
TG1,
%
TG2,
%
TG3,
 %
2, p value
(log-rank)
LPs 1.8080.05 94 62 31 17.0, p < 0.001
Rater A/1 1.9680.06 98 60 52 17.9, p < 0.001
Rater A/2 2.0180.06 100 64 50 17.5, p < 0.001
Rater B/1 1.6080.05 89 63 18 35.6, p < 0.001
Rater B/2 1.6180.06 88 64 18 35.3, p < 0.001
LPs = Local pathologists. S ee text for details of how the ‘mean 
grades’ were calculated. The 2 values indicate the magnitude of 
the discriminative power of the different survival curves present-
ed. The log-rank test was used as an overall test to compare the 
Kaplan-Meier survival curves for TG1, TG2 and TG3 penile can-
cer with respect to CSS. TG1–3 = Tumor grades G1–G3 (Broders’ 
grade G4 did not occur in the present series).
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ILND to be performed, a procedure not to be underesti-
mated in terms of its possible comorbidity  [2–9] .
 We found substantial interobserver discordance, espe-
cially between the G2 and G3 categories in pT1 PSCCs 
( table 2 ;  fig. 2 ), which continued to be present even after 
conducting a joint meeting, suggesting inherent ‘aggres-
sive’ versus ‘reserved’ individual grading characteristics 
of the participating raters.
 However, it is likely that conventional histopathology 
will continue to guide clinical management of PSCC pa-
tients in the future since alternative strategies for investi-
gating nodal involvement (e.g. dynamic sentinel node bi-
opsy or ultrasound-guided fine needle aspiration) suffer 
from false-negative rates, and none of the recently report-
ed prognostic biomarkers has been implemented on a 
regular basis in clinical practice yet  [10, 17–23] .
 Fig. 1. G1 or G2 squamous cell carcinoma? This study case was 
graded as G1 by the ‘reserved’ rater B (with the lowest ‘mean 
grade’) and as G2 by the ‘aggressive’ rater A (with the highest 
‘mean grade’). HE.  ! 10. 
 Fig. 2. G2 or G3 squamous cell carcinoma? This study case was 
graded as G2 by the ‘reserved’ rater B (with the lowest ‘mean 
grade’) and as G3 by the ‘aggressive’ rater A (with the highest 
‘mean grade’). HE.  ! 10. 
Table 5. U nivariable regression analysis to predict CSS in 147 patients with surgically treated PSCC
Predictor HR (95% CI) SE p value
Age (continuous) 1.00 (0.97–1.03) 0.02 0.824
Total penectomy (referent: partial or excision) 3.32 (1.72–6.44) 0.34 <0.001
Tumor size (continuous) 1.23 (1.01–1.49) 0.09 0.039
Tumor thickness >5 mm (referent: ≤5 mm) 3.20 (1.25–8.25) 0.48 0.016
LVI present (referent: absent) 11.38 (4.95–26.17) 0.42 <0.001
pT stage (4 categories) 2.84 (1.94–4.15) 0.19 <0.001
pN+ (referent: pN0/pNx) 9.41 (4.76–18.60) 0.35 <0.001
Year of surgery (continuous) 0.98 (0.89–1.09) 0.08 0.735
Tumor grade 
Local pathology (3 categories) 3.08 (1.78–5.33) 0.28 <0.001
Rater A/1 (3 categories) 2.41 (1.52–3.83) 0.23 <0.001
Rater A/2 (3 categories) 2.65 (1.61–4.34) 0.25 <0.001
Rater B/1 (3 categories) 3.40 (2.16–5.34) 0.23 <0.001
Rater B/2 (3 categories) 3.39 (2.15–5.34) 0.23 <0.001
HR = Hazard ratio.
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 Participation in web-based tutorials might represent a 
step forward in the standardization of education and 
training in histopathology  [24] . However, regular partici-
pation which might be rewarded by the possibility of 
earning education credit points in order to meet the need 
of pathology trainees as the principal target group would 
certainly be necessary in order to prevent participants 
from reverting to their original form shortly after the ses-
sions are over. The latter phenomenon is likely to have oc-
curred in our study, accounting for substantial interob-
server discordance even after conducting a joint meeting. 
Our findings are in line with the advanced study recently 
conducted by Naumann et al.  [1] on 75 patients with 
PSCC. Briefly, this study was the first to report on the sig-
nificant interobserver variation with respect to the grad-
ing of penile cancer. However, the magnitude of the prog-
nostic impact entailed by this interobserver discordance 
was not addressed in that study. In comparison, our data 
not only demonstrated a great extent of rater dependency 
obviously attributable to inherent grading characteristics 
of individual pathologists but, by employing the ‘mean 
grade per pathologist’, also showed the magnitude of the 
prognostic implications linked to this discordance.
 There are a few limitations to our study in addition to 
its retrospective nature. Our evaluation was restricted to 
the BGS. However, this stipulation seems to be justified 
since the BGS continues to be the most commonly em-
ployed system for grading of PSCCs  [25, 26] . Broders’ 
grade 4 did not occur in our series, suggesting that it is a 
rarity. However, to our knowledge, there are no data on its 
‘true’ incidence available in the literature. Otherwise, the 
distribution of our grading categories (G1–G3;  table 2 ) is 
in line with other studies using a three-tiered grading sys-
tem  [2–6, 26, 27] . ILND was performed in only 48 patients 
(33%) of our study cohort, which precludes reliable evalu-
ation of the impact of histologic grade on nodal involve-
ment. Moreover, a possible change in chemotherapeutic 
regimens administered during our sampling period can-
not be excluded. However, the lack of significance of the 
hazard ratios for the year of surgery adjusted to all perti-
nent prognostic parameters strongly indicates that CSS 
was not influenced by treatment protocols.
 In conclusion, conventional histopathology might 
strongly guide clinical management of PSCC patients at 
present. The substantial interobserver discordance as 
well as the dependency of the prognostic impact con-
veyed by the BGS on the individual pathologist seems, at 
least in part, to be attributable to inherent grading char-
acteristics of individual pathologists. Therefore, until 
more reproducible criteria to render the BGS more objec-Ta
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tive or novel biomarkers to be determined by the pathol-
ogist on a perhaps regular basis become available to guide 
clinical management, standardization of histopathology 
training on a perhaps regular basis might be helpful in 
refining grading of PSCCs.
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